PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.
Introduction: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon and ribavirin in patients with sickle cell disease and hepatitis C virus (HCV) infection are scanty. Objective: In this study, our aim was to evaluate the safety and efficacy of antiviral therapy wit...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1742 |